PAREXEL

Type: Company
Name: PAREXEL
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Disruptors bring innovation to CTMS market

OVUM VIEWSummaryThe complexity and cost of conducting clinical trials has been steadily increasing and is threatening the profitability of drug candidates and the economic feasibility of drug discovery research projects. As a result, the development stage ... [Published Ovum - 3 hours ago]
First reported 8 hours ago - Updated 8 hours ago - 1 reports

Benchmarking the Pharma Industry's HEOR Functions

Research and Markets (http://www.researchandmarkets.com/research/82dkkj/benchmarking_the) has announced the addition of the " " report to their offering. Informing the drug development and commercialization industry This study surveyed 106 pharmaceutical ... [Published Individual.com - 8 hours ago]
First reported Jul 02 2014 - Updated Jul 03 2014 - 3 reports

PAREXEL Announces Acquisition of ATLAS Medical Services

Acquisition strengthens PAREXEL’s presence in Turkey, the Middle East and North Africa. ... [Published Technology Networks - Jul 03 2014]
Entities: PAREXEL, Acquisition, Turkey
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

Taiwan recognizes Parexel as best CRO

Singapore: Foundation of Medical Professionals Alliance in Taiwan (FMPAT) has recognized contract research firm, PAREXEL, as the 2014 Best Performing CRO in Taiwan."Parexel applies its scientific expertise and innovative approaches to reducing clinical ... [Published Bio Spectrum Asia - Jul 02 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 4 reports

Research and Markets: Overview of Japanese CRO Market 2014 Featuring Cimic, EPS, Mediscience Planning, Parexel & Quintiles

First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

Parexel expects to hit the $2B mark in fiscal 2015

Parexel ($PRXL) figures it can rake in more than $2 billion in revenue in the next fiscal year, banking on a solid book-to-bill ratio and increasing global demand to deliver an all-time high.The CRO is expecting between $2.1 billion and $2.2 billion in ... [Published Fierce CRO - Jun 30 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

PAREXEL upgraded to Outperform at RW Baird

As reported previously, Baird raised its rating on PAREXEL to Outperform from Neutral citing valuation and accelerated earnings growth. The firm raised its price target on the stock to $64 from $55.Finance Investment & Company Information PAREXEL ... [Published Yahoo! Finance - Jun 26 2014]
First reported Jun 23 2014 - Updated Jun 24 2014 - 1 reports

PAREXEL Named 2014 Best Performing CRO In Taiwan For Drug Development And Healthcare Industry Leadership

Company recognized by Foundation of Medical Professionals Alliance in Taiwan ... [Published CEOWorld Magazine - Jun 23 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Parexel hones in on risk-based monitoring with new tool

CRO Parexel has officially launched its Perceptive MyTrials Data-Driven Monitoring tool to help sponsors develop risk-based monitoring strategies.The Parexel tool offers a new approach to centralized risk-based monitoring as it can capture, consolidate ... [Published Outsourcing Pharma - Jun 19 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

PAREXEL Wins 2014 IABC Gold Quill Merit Award For Internal Communications

International recognition for driving business performance through effective employee engagement ... [Published RCL Advisors - Jun 19 2014]
Entities: PAREXEL
First reported Jun 18 2014 - Updated Jun 18 2014 - 1 reports

PAREXEL : Cuts Clinical Trial Start-Up Time For Sponsors By Weeks With New Version Of Industry-Leading ClinPhone RTSM Services

Biopharmaceutical companies are increasingly seeking to make drug development more efficient without compromising patient safety or data quality. Efficiency is particularly critical at the start of clinical trials, when clients must simultaneously initiate ... [Published 4 Traders - Jun 18 2014]
First reported Jun 17 2014 - Updated Jun 17 2014 - 3 reports

Barnett International Announces the Release of the PAREXEL Biopharmaceutical Statistical Sourcebook 2014/2015

NEEDHAM, MA -- (Marketwired) -- 06/17/14 -- Barnett International announces the release of the 2014/2015 edition of the PAREXEL Biopharmaceutical Statistical Sourcebook. This annual compendium is the leading resource for statistics, trends, and proprietary ... [Published Stock Nod - Jun 17 2014]

Quotes

Josef von Rickenbach, chairman and chief executive officer of PAREXEL said, "The acquisition of ATLAS strengthens PAREXEL's presence in Turkey, the Middle East and North Africa. These markets are of increasing importance to our clients who are looking for market access and a broad spectrum of patient populations for clinical trials. In addition, ATLAS has been a trusted business partner to PAREXEL for many years, and their infrastructure and staff are already aligned with our processes and operations. By fully integrating ATLAS into PAREXEL's global operations, we will enhance our ability to help clients more quickly achieve their goals of bringing important therapies to patients not only in Turkey, the Middle East, and North Africa, but also throughout the rest of the world."
...trials that include APAC as well as region and country-specific needs," said Mr Mark A Goldberg, president and chief operating officer, Parexel. "With 4,400 employees in 23 locations across 12 countries in the region, PAREXEL offers an unparalleled infrastructure to support customers across the entire development continuum."
Transparency Market Research has published a new report titled "Clinical Trial Management System Market: Global Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2019" to its report store...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pqjm3l/the_overview_of) has announced the addition of the "Overview of Japanese CRO Market 2014 Featuring Cimic, EPS, Mediscience Planning, Parexel & Quintiles " report to their offering. Japanese CROs get local projects, and global CROs take global studies...

More Content

All (83) | News (68) | Reports (0) | Blogs (14) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Disruptors bring innovation to CTMS market [Published Ovum - 3 hours ago]
Benchmarking the Pharma Industry's HEOR Functions [Published Individual.com - 8 hours ago]
KEMH Appoints New Consultant Geriatrician [Published Bernews - Jul 05 2014]
Top 5 Trends in Clinical Partnering and Outsour... [Published Terrapinn - Jul 03 2014]
2014 Report on the Japanese CRO Market [Published The CW44 Tampa Bay - Jul 03 2014]
PAREXEL Announces Acquisition of ATLAS Medical ... [Published Technology Networks - Jul 03 2014]
PAREXEL Acquires ATLAS\n [Published Contract Pharma - Jul 02 2014]
Parexel acquires Turkish firm [Published Bio Spectrum Asia - Jul 02 2014]
Taiwan recognizes Parexel as best CRO [Published Bio Spectrum Asia - Jul 02 2014]
Clinical Trial Management System Market: Global... [Published PRWeb - Jul 01 2014]
Research and Markets: Overview of Japanese CRO ... [Published Digital Journal - Jun 30 2014]
Research and Markets: Overview of Japanese CRO ... [Published Business Wire Science: Science News - Jun 30 2014]
Research and Markets: Overview of Japanese CRO ... [Published Business Wire Health News - Jun 30 2014]
Celerion expands in to Asia and finds partners ... [Published Partnerships in Clinical Trials - Jun 30 2014]
Parexel expects to hit the $2B mark in fiscal 2015 [Published Fierce CRO - Jun 30 2014]
Healthcare Outsourcing Market (Claims Processin... [Published Individual.com - Jun 30 2014]
Overview of Japanese CRO Market 2014 Featuring ... [Published Individual.com - Jun 30 2014]
London-Cambridge-Oxford golden triangle is a 't... [Published Cambridge Network - Jun 30 2014]
Top Analysts Action: NMBL, PRXL, ZU, PF, EL [Published BayStreet.ca - Jun 26 2014]
Stock Upgrades: Zulily's Gains Won't Be Gone in... [Published Minyanville - Jun 26 2014]
Analysts' Actions: Amazon, Facebook, Google, Ne... [Published TheStreet.com - Jun 26 2014]
PAREXEL upgraded to Outperform at RW Baird [Published Yahoo! Finance - Jun 26 2014]
Analysts' Actions: Amazon, Facebook, Google, Ne... [Published The Street Latest - Jun 26 2014]
Weak Data Could Aggravate Market Worries [Published RTTNews.com - Jun 25 2014]
Wall Street Momentum Falters Amid Caution [Published RTTNews.com - Jun 25 2014]
BioClinica dives into adaptive trials with late... [Published Fierce CRO - Jun 23 2014]
Opinion: Pharma follows as the CROs fly [Published Local Tech Wire - Jun 23 2014]
PAREXEL Named 2014 Best Performing CRO In Taiwa... [Published CEOWorld Magazine - Jun 23 2014]
Biosimilars provide new growth options [Published Ecns.cn - Jun 23 2014]
Healthcare's next frontier [Published Ecns.cn - Jun 23 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Research and Markets: Overview of Japanese CRO ... [Published Business Wire Science: Science News - Jun 30 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pqjm3l/the_overview_of) has announced the addition of the "Overview of Japanese CRO Market 2014 Featuring Cimic, EPS, Mediscience Planning, Parexel & Quintiles " ...
Research and Markets: Overview of Japanese CRO ... [Published Business Wire Health News - Jun 30 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pqjm3l/the_overview_of) has announced the addition of the "Overview of Japanese CRO Market 2014 Featuring Cimic, EPS, Mediscience Planning, Parexel & Quintiles " ...
Celerion expands in to Asia and finds partners ... [Published Partnerships in Clinical Trials - Jun 30 2014]
This year, Celerion , they bring their expertise in early stage clinical trials and bioanalysis while the KDDF will profit by working with a company who can bring their Korean drug discoveries to a global market.Celerion has put an emphasis on taking ...
Barnett International Announces the Release of ... [Published Marketwire - Breaking News Releases - Jun 17 2014]
NEEDHAM, MA--(Marketwired - Jun 17, 2014) - Barnett International announces the release of the 2014/2015 edition of the PAREXEL Biopharmaceutical Statistical Sourcebook. This annual compendium is the leading resource for statistics, trends, and proprietary ...
Research and Markets: Life Sciences BPO Market ... [Published Business Wire Health News - May 02 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/kwcfzm/life_sciences_bpo) has announced the addition of the "Life Sciences BPO Market Report with Forecasts to 2019: Contract Research Organizations & Contract Manufacturing ...
1 2 3

Press Releases

sort by: Date | Relevance
BlueSnap taps Sobo as CFO -- 05:46:10(CST)1-31-... [Published PR Newswire via Green Sheet - Feb 01 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.